September 8, 2024
Headlines

Biotech

Sonoma Biotherapeutics Secures $45 Million Milestone Payment from Regeneron in Transformative Collaboration

Editor04 mins

Sonoma Biotherapeutics, Inc., a leading clinical-stage biotechnology firm specializing in engineered regulatory T cell (Treg) therapies, has achieved a significant milestone with a $45 million payment from Regeneron Pharmaceuticals, Inc. This milestone underscores the fruitful partnership between the two companies in developing advanced treatments for autoimmune diseases. The payment marks a pivotal point in Sonoma…

Read More

eGenesis Secures $191 Million in Series D Funding to Propel Kidney Transplant Innovation

Editor05 mins

eGenesis, a trailblazer in biotechnology with a focus on developing human-compatible engineered organs, has announced the successful completion of a $191 million Series D financing round. This substantial investment will propel the advancement of eGenesis’s lead product candidate, EGEN-2784, through its first-in-human clinical trials for kidney transplants. Additionally, the funds will facilitate the expansion of…

Read More

ArsenalBio Raises $325 Million in Landmark Series C Round to Accelerate Breakthrough Cell Therapies for Solid Tumors

Editor05 mins

Arsenal Biosciences, Inc. (ArsenalBio), a pioneering force in programmable cell therapy, has announced the successful closure of an oversubscribed $325 million Series C financing round. This significant funding boost reflects a growing confidence in ArsenalBio’s innovative approach to advanced CAR T-cell therapies targeting solid tumors. The Series C round attracted a host of new investors,…

Read More

AcuraStem Lands $4 Million CIRM Grant to Transform ALS and FTD Treatment

Editor04 mins

AcuraStem, a leading biotechnology firm renowned for its patient-centered approach to treating neurodegenerative disorders, has announced a pivotal development in its research efforts. The company has been awarded $4 million in grant funding by the California Institute for Regenerative Medicine (CIRM). This substantial investment will bolster AcuraStem’s innovative work on its targeted therapeutic program focusing…

Read More

Noetik Secures $40 Million in Series A Funding to Revolutionize Cancer Therapeutics

Editor08 mins

Noetik, a pioneering AI-native biotechnology firm dedicated to advancing precision cancer therapies, has successfully closed a substantial $40 million Series A financing round. This oversubscribed round was spearheaded by Polaris Partners, with Amy Schulman, Managing Partner, joining Noetik’s board of directors. The funding also saw participation from notable new investors including Khosla Ventures, Wittington Ventures,…

Read More

ZBiotics Secures $12 Million in Series A Funding to Expand Revolutionary Probiotic Line

Editor05 mins

ZBiotics, a trailblazer in the realm of genetically engineered probiotics, has successfully concluded its $12 million Series A funding round. The investment, led by Spring Tide Capital and supported by Access Capital, Seamless Capital, Goat Rodeo Capital, and Seaside Ventures, marks a significant milestone for the company. The funds are set to fuel ZBiotics‘ plans…

Read More

IceCure’s ProSense® Delivers 100% Success Rate in Breakthrough Cryoablation Study, Paving the Way for Non-Surgical Breast Cancer Treatment

Editor04 mins

IceCure Medical Ltd has announced a landmark achievement with its ProSense® cryoablation system, as detailed in a recent study published in the British Journal of Radiology. The study, conducted at Hospital Lucus Augusti in Lugo, Spain, demonstrates a 100% complete ablation rate for luminal A and B breast cancer tumors ≤ 25mm after a median…

Read More

Halda Therapeutics Garners $126 Million in Series B Extension to Propel Innovative Cancer Treatments into Clinical Trials

Editor06 mins

Halda Therapeutics, a leading biotechnology firm renowned for its pioneering cancer therapies, has successfully raised $126 million in a Series B extension. This latest funding round saw significant participation from premier investors, including Deep Track Capital, Frazier Life Sciences, RA Capital Management, Vida Ventures, Boxer Capital, and Taiho Ventures. Existing backers such as Canaan Partners,…

Read More
Founders Floris Engelhardt, John Vroom, Mark Bathe

Kano Therapeutics Secures $7.1 Million in Funding to Revolutionize Genetic Medicine with Non-Viral DNA Insertion

Editor05 mins

Kano Therapeutics, a forward-thinking biotechnology firm emerging from MIT, has announced the successful closure of a $7.1 million funding round, underscoring its potential to reshape the landscape of genetic medicine. This financing includes an oversubscribed $5 million seed round co-led by The Engine Ventures and VSquared Ventures, with additional support from Taihill Venture and Metaplanet….

Read More

Amulet Secures $6 Million in Series A Funding to Revolutionize Food Allergen Detection

Editor06 mins

Amulet, an innovator in food safety technology, has successfully raised $5.8 million in Series A financing. This round, spearheaded by HealthX Ventures, also saw participation from Incite Ventures, AllerFund, Mendota Venture Capital, Great Oaks Venture Capital, and notable individuals including Pinterest executive Julie Bornstein and investor Diede van Lamoen. The investment will propel Amulet’s mission…

Read More